A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793) Meeting Abstract
| Authors: | Rogue, D. M.; Bellone, S.; Siegel, E. R.; Buza, N.; Bonazzoli, E.; Guglielmi, A.; Zammataro, L.; Nagarkatti, N.; Zaidi, S.; Lee, J.; Schwartz, P. E.; Ratner, E.; Alexandrov, L. B.; Iwasaki, A.; Kong, Y.; Song, E.; Dong, W.; Elvin, J. A.; Choi, J.; Santin, A. |
| Abstract Title: | A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603126 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.5523 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5523 -- Source: Wos |
